Lucid Diagnostics Capital Expenditures (CapEx) Growth & History (LUCD)

Lucid Diagnostics's capital expenditures (capex) was $197,000 for fiscal 2025.

View full Lucid Diagnostics company overview

Lucid Diagnostics annual capital expenditures (capex) history

Lucid Diagnostics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$197,000−$99,000−33.45%
20242024-12-31$296,000$75,000+33.94%
20232023-12-31$221,000−$3.0M−93.09%
20222022-12-31$3.2M$2.3M+271.23%
20212021-12-31$862,000

Lucid Diagnostics capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, Lucid Diagnostics's capital expenditures (capex) decreased from $862,000 to $197,000, a change of −$665,000. The latest reported quarter, Q2 2026, shows $21,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lucid Diagnostics source filings ↗

Community posts

It’s quiet here.

No posts about LUCD yet. Start the conversation.

Write the first post